Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing

Charles River Laboratories International, Inc.  announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The pl...

September 27, 2023 | Wednesday | News
Merck Becomes First CTDMO to Offer Comprehensive mRNA Development and Manufacturing Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | Wednesday | News
Lonza's Sudden CEO Departure: What's Behind the Curtain?

"Swiss CDMO Lonza Announces CEO Departure by Mutual Agreement; Chairman Baehny Takes the Helm Again Temporarily" Lonza, the Swiss Contract Development and...

September 18, 2023 | Monday | News
Syneos Health and Oracle Partner to Advance Patient Recruitment and Health Equity

Syneos Health is evolving its patient recruitment capabilities to further address unmet sponsor, site and patient needs. Through its collaboration with the...

September 13, 2023 | Wednesday | News
CDMO player Enzene Biosciences opens new R&D centre in India

  Enzene Biosciences, a subsidiary of Mumbai-India, based Alkem Laboratories, has announced the inauguration of its cutting-edge research and...

September 07, 2023 | Thursday | News
First Patient Dosed with ISA104 in Phase 1 Study for Chronic Hepatitis B

ISA Pharmaceuticals B.V., a clinical-stage biotech company developing immunotherapies to treat cancers and serious infectious diseases, is pleased to ...

September 04, 2023 | Monday | News
Cellares Raises $255M Series C to Launch Pioneering Cell Therapy Smart Factory

Series C is led by Koch Disruptive Technologies and includes Bristol Myers Squibb, DFJ Growth, Willett Advisors and existing investors Eclipse, Dech...

August 24, 2023 | Thursday | News
WuXi XDC and Boostimmune Sign MOU for Integrated Services

Under the collaboration, Boostimmune will have access to WuXi XDC's fully integrated, one-stop bioconjugate platform and extensive expertise in industry-le...

August 11, 2023 | Friday | News
WuXi Vaccines' First Drug Substance Facility in China Now GMP-Ready

The GMP release of its first DS facility in China enhances WuXi Vaccines' capability in providing global partners with comprehensive end-to-end solutions, ...

July 28, 2023 | Friday | News
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

“Samsung Biologics is fully committed to engaging in sustainable business practices for the positive impact it has on our clients, society, and the w...

July 18, 2023 | Tuesday | News
Paras Biopharma Enhances Protein Expression in Microbial Systems for Cost-effective Biologics Production

The company is pleased to disclose its advancement of up to 12 g or more / L expression of recombinant protein - fully folded / biologically active in ferm...

July 04, 2023 | Tuesday | News
WuXi Biologics Announced Global Strategic Partnership with Pharmadule Morimatsu at its Singapore CRDMO Center Project

Under the partnership, Pharmadule Morimatsu will provide modular facilities for the WuXi Biologics Singapore CRDMO Center project.   This strategic ...

June 29, 2023 | Thursday | News
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology

By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...

June 28, 2023 | Wednesday | News
Vetter Continues to Lead the Industry in Sustainability Initiatives

Report now includes Scope 3 emissions Employee-driven social responsibility takes precedence as driving force for sustainability activities Goal to red...

June 15, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close